Gregory Cairncross
University of Calgary
H-index: 89
North America-Canada
Top articles of Gregory Cairncross
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
QOL-18. HIGHER VINCRISTINE DOSES CORRELATE WITH LONGER OVERALL SURVIVAL: A POST-HOC ANALYSIS OF PARTICIPANTS RECEIVING PCV ON RTOG 9402 | Neuro-Oncology | Laura Donovan Mei-Yin Polly J Gregory Cairncross Andrew Lassman Fabio Iwamoto | 2023/11/1 |
Mitogen-induced defective mitosis transforms neural progenitor cells | Neuro-oncology | Hiba K Omairi Cameron J Grisdale Mathieu Meode Alexandra K Bohm Sophie Black | 2023/10/1 |
PDGF gene expression and p53 alterations contribute to the biology of diffuse astrocytic gliomas | NPJ Genomic Medicine | Mehul Kumar Mathieu Meode Michael Blough Gregory Cairncross Pinaki Bose | 2023/2/25 |
Corrigendum to: Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE. 6 (EORTC 26062-22061, TROG 08.02) randomized … | Neuro-Oncology Advances | Andrew J Song Keyue Ding Iyad Alnahhas Normand J Laperriere James Perry | 2022/1/1 |
Joint final report of EORTC 26951 and RTOG 9402: phase III trials with procarbazine, lomustine, and vincristine chemotherapy for anaplastic oligodendroglial tumors | Journal of Clinical Oncology | Andrew B Lassman Khê Hoang-Xuan Mei-Yin C Polley Alba A Brandes J Gregory Cairncross | 2022/8/8 |
Single-cell landscapes of primary glioblastomas and matched explants and cell lines show variable retention of inter-and intratumor heterogeneity | Cancer Cell | Véronique G LeBlanc Diane L Trinh Shaghayegh Aslanpour Martha Hughes Dorothea Livingstone | 2022/4/11 |
CODEL: phase III study of RT, RT+ TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design | Neuro-oncology | Kurt A Jaeckle Karla V Ballman Martin Van Den Bent Caterina Giannini Evanthia Galanis | 2021/3/1 |
Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE. 6 (EORTC 26062-22061, TROG08. 02) randomized clinical trial | Andrew Jehyun Song Keyue Ding Normand Laperriere James R Perry Warren P Mason | 2020/5/20 | |
NCOG-12. COGNITIVE FUNCTION (CF) & QUALITY OF LIFE (QOL) IN PATIENTS TREATED WITH PROCARBAZINE, CCNU, & VINCRISTINE (PCV)+ RADIOTHERAPY (RT) VS. RT FOR ANAPLASTIC … | Neuro-Oncology | Laura Donovan Minhee Won J Gregory Cairncross Fabio Iwamoto Jan Buckner | 2021/11/2 |
Clinical Neuropathological Conference: There’sa Child in All of Us | Canadian Journal of Neurological Sciences | Alan Chalil JG Cairncross Cynthia Hawkins Andrew E Leung Matthew Hebb | 2021/11 |
Copy-scAT: Deconvoluting single-cell chromatin accessibility of genetic subclones in cancer | Science advances | Ana Nikolic Divya Singhal Katrina Ellestad Michael Johnston Yaoqing Shen | 2021/10/13 |
In the beginning: PDGFA and the genesis of GBM | Neuro-oncology | Michael D Blough Mehul Kumar Pinaki Bose J Gregory Cairncross | 2021/4/1 |
Temozolomide does not meaningfully reduce seizure frequency in elderly glioblastoma patients (614) | Seth Climans Alba Brandes J Greg Cairncross Keyue Ding Michael Fay | 2020/4/14 | |
Development of a peptide-based delivery platform for targeting malignant brain tumors | Biomaterials | Jennifer J Rahn Xueqing Lun Selina K Jorch Xiaoguang Hao Chitra Venugopal | 2020/9/1 |
Multicentric registry study on epidemiological and biological disease profile as well as clinical outcome in patients with low-grade gliomas: The LoG-Glio Project | Journal of Neurological Surgery Part A: Central European Neurosurgery | Andrej Pala Minou Nadji-Ohl Katharina Faust Stefan Rückriegel Constantin Roder | 2020/1 |
In vitro modeling of glioblastoma initiation using PDGF-AA and p53-null neural progenitors | Neuro-oncology | Alexandra K Bohm Jessica DePetro Carmen E Binding Amanda Gerber Nicholas Chahley | 2020/8/17 |
Proceedings of the comprehensive oncology network evaluating rare CNS tumors (NCI-CONNECT) adult medulloblastoma workshop | Marta Penas-Prado Brett J Theeler Brittany Cordeiro Ira J Dunkel Peter Hau | 2020/1 | |
Molecular Determinants of Prognosis and Evolution in Diffuse-Lower Grade Astrocytomas | bioRxiv | Mehul Kumar J Gregory Cairncross Michael D Blough Pinaki Bose | 2020/8/4 |
EPCO-06. MOLECULAR DETERMINANTS OF EVOLUTION AND PROGNOSIS AMONG DIFFUSE LOWER GRADE ASTROCYTOMAS | Neuro-Oncology | Mehul Kumar Gregory Cairncross Michael Blough Pinaki Bose | 2020/11 |
Temozolomide and seizure outcomes in a randomized clinical trial of elderly glioblastoma patients | Journal of Neuro-Oncology | Seth A Climans Alba A Brandes J Gregory Cairncross Keyue Ding Michael Fay | 2020/7/6 |
